Eco R1 Capital, LLC Syros Pharmaceuticals, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.08 - $5.66 $4.08 Million - $5.66 Million	-1,000,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $6.66 Million - $14.7 Million	1,000,000 New	1,000,000 $10.9 Million
Q3 2019 Nov 14, 2019	SELL	$7.14 - $11.65 $1.77 Million - $2.89 Million	-248,480 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $1.37 Million - $2.42 Million	248,480 New	248,480 $2.3 Million
Q4 2017 Feb 14, 2018	SELL	$8.45 - $17.48 $878,799 - $1.82 Million	-104,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $1.41 Million - $2.47 Million	104,000	104,000 $1.53 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.